65 I B, drugs, pharmaceuticals,&hematology related products, FSS contract award
Ended Awarded Last action
- Contract number
- 36F79719D0170
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 128
Award facts
- Opportunity
-
- M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment Pre-Solicitation · M5Q50A03R8 · Posted Jun 21, 2018
- Last date to order 100% complete
- IDV ceiling
- $225,000.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
The key products and services being delivered under this federal contract IDV are PYLARIFY (piflufolastat F-18), a radiopharmaceutical drug used for positron emission tomography (PET) imaging of prostate cancer. The prime contractor is Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and a subsidiary of Lantheus Holdings, Inc. The contract vehicles include several Blanket Purchase Agreements (BPAs) awarded by the U.S. Department of Veterans Affairs (VA) and the Defense Health Agency (DHA), with ceiling values ranging from $250,000 to $6.5 million. These BPAs, issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), allow various VA medical facilities and military treatment centers to issue task orders for the procurement of PYLARIFY to support their cancer detection and treatment programs. The contracts are predominantly not set aside for small businesses, though a few have been designated as total small business set-asides. The task orders have firm fixed pricing and periods of performance spanning multiple years, typically from 2023 to 2028. These contract vehicles enable Lantheus Holdings and its subsidiaries to provide critical radiopharmaceutical products to federal healthcare agencies, particularly the VA and DHA, to improve cancer diagnosis and treatment for veterans and military personnel.
Task orders
Show 40 more
Latest 50 of 128 listed here. See the rest on GovTribe.
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36C24824A0038 | Veterans Integrated Service Network 8 (VHA) | $2,634,366 | |
| 36C24823A0018 | Veterans Integrated Service Network 8 (VHA) | $5,728,216 | |
| 36C25523A0018 | Veterans Integrated Service Network 15 (VHA) | $1,188,615 | |
| 36C26123A0025 | Veterans Integrated Service Network 21 (VHA) | $5,500,000 | |
| 36C26123A0014 | Veterans Integrated Service Network 21 (VHA) | $5,500,000 | |
| 36C24923A0010 | Veterans Integrated Service Network 9 (VHA) | $4,304,123 | |
| 36C25222A0035 | Veterans Integrated Service Network 12 (VHA) | $1,381,605 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 23
Quick answers
Who was awarded contract 36F79719D0170?
36F79719D0170 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on June 15, 2019.
How much is contract 36F79719D0170 worth?
36F79719D0170's own ceiling is $225,000.
How many orders have been placed under contract 36F79719D0170?
128 orders have been placed under 36F79719D0170, the latest on November 1, 2026.
Who can order from contract 36F79719D0170?
36F79719D0170 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79719D0170 part of a contract vehicle?
Yes. 36F79719D0170 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79719D0170 competed?
The extent of competition for 36F79719D0170 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV